These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 32003991)
21. Probing the cathepsin D using a BODIPY FL-pepstatin A: applications in fluorescence polarization and microscopy. Chen CS; Chen WN; Zhou M; Arttamangkul S; Haugland RP J Biochem Biophys Methods; 2000 Mar; 42(3):137-51. PubMed ID: 10737220 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of cathepsin D by tripeptides containing statine analogs. Bessodes M; Antonakis K; Herscovici J; Garcia M; Rochefort H; Capony F; Lelièvre Y; Scherman D Biochem Pharmacol; 1999 Jul; 58(2):329-33. PubMed ID: 10423175 [TBL] [Abstract][Full Text] [Related]
23. Cathepsin D as a Promising Target for the Discovery of Novel Anticancer Agents. Dubey V; Luqman S Curr Cancer Drug Targets; 2017; 17(5):404-422. PubMed ID: 28215160 [TBL] [Abstract][Full Text] [Related]
24. Cathepsin D propeptide: mechanism and regulation of its interaction with the catalytic core. Mása M; Maresová L; Vondrásek J; Horn M; Jezek J; Mares M Biochemistry; 2006 Dec; 45(51):15474-82. PubMed ID: 17176069 [TBL] [Abstract][Full Text] [Related]
25. Structure-Activity Relationships of JMV4463, a Vectorized Cathepsin D Inhibitor with Antiproliferative Properties: The Unique Role of the AMPA-Based Vector. Vezenkov LL; Sanchez CA; Bellet V; Martin V; Maynadier M; Bettache N; Lisowski V; Martinez J; Garcia M; Amblard M; Hernandez JF ChemMedChem; 2016 Feb; 11(3):302-8. PubMed ID: 26639308 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and structure activity relationships of novel small molecule cathepsin D inhibitors. Dumas J; Brittelli D; Chen J; Dixon B; Hatoum-Mokdad H; König G; Sibley R; Witowsky J; Wong S Bioorg Med Chem Lett; 1999 Sep; 9(17):2531-6. PubMed ID: 10498202 [TBL] [Abstract][Full Text] [Related]
27. Cathepsin D protects colorectal cancer cells from acetate-induced apoptosis through autophagy-independent degradation of damaged mitochondria. Oliveira CS; Pereira H; Alves S; Castro L; Baltazar F; Chaves SR; Preto A; Côrte-Real M Cell Death Dis; 2015 Jun; 6(6):e1788. PubMed ID: 26086961 [TBL] [Abstract][Full Text] [Related]
28. Characterisation of hydrazides and hydrazine derivatives as novel aspartic protease inhibitors. Ahmed W; Rani M; Khan IA; Iqbal A; Khan KM; Haleem MA; Azim MK J Enzyme Inhib Med Chem; 2010 Oct; 25(5):673-8. PubMed ID: 20063996 [TBL] [Abstract][Full Text] [Related]
29. Structural basis for inhibition of cathepsin B drug target from the human blood fluke, Schistosoma mansoni. Jílková A; Řezáčová P; Lepšík M; Horn M; Váchová J; Fanfrlík J; Brynda J; McKerrow JH; Caffrey CR; Mareš M J Biol Chem; 2011 Oct; 286(41):35770-35781. PubMed ID: 21832058 [TBL] [Abstract][Full Text] [Related]
30. Acetate-induced apoptosis in colorectal carcinoma cells involves lysosomal membrane permeabilization and cathepsin D release. Marques C; Oliveira CS; Alves S; Chaves SR; Coutinho OP; Côrte-Real M; Preto A Cell Death Dis; 2013 Feb; 4(2):e507. PubMed ID: 23429293 [TBL] [Abstract][Full Text] [Related]
31. Cathepsin D inhibitors based on tasiamide B derivatives with cell membrane permeability. Li Z; Li H; Jiang F; Wang Z; Zhang W Bioorg Med Chem; 2022 Mar; 57():116646. PubMed ID: 35121401 [TBL] [Abstract][Full Text] [Related]
32. Grassystatin-derived peptides selectively inhibit cathepsin E and have low affinity to cathepsin D. Stotz S; Bleher D; Kalbacher H; Maurer A Biochem Biophys Res Commun; 2020 Jun; 527(1):238-241. PubMed ID: 32446374 [TBL] [Abstract][Full Text] [Related]
34. Crystal structures of Aspergillus oryzae aspartic proteinase and its complex with an inhibitor pepstatin at 1.9A resolution. Kamitori S; Ohtaki A; Ino H; Takeuchi M J Mol Biol; 2003 Mar; 326(5):1503-11. PubMed ID: 12595261 [TBL] [Abstract][Full Text] [Related]
35. Atomic resolution crystal structure of Sapp2p, a secreted aspartic protease from Candida parapsilosis. Dostál J; Pecina A; Hrušková-Heidingsfeldová O; Marečková L; Pichová I; Řezáčová P; Lepšík M; Brynda J Acta Crystallogr D Biol Crystallogr; 2015 Dec; 71(Pt 12):2494-504. PubMed ID: 26627656 [TBL] [Abstract][Full Text] [Related]
36. High-speed optimization of inhibitors of the malarial proteases plasmepsin I and II. Nöteberg D; Schaal W; Hamelink E; Vrang L; Larhed M J Comb Chem; 2003; 5(4):456-64. PubMed ID: 12857114 [TBL] [Abstract][Full Text] [Related]
37. Potent and selective inhibitors of an aspartyl protease-like endothelin converting enzyme identified in rat lung. Shiosaki K; Tasker AS; Sullivan GM; Sorensen BK; von Geldern TW; Wu-Wong JR; Marselle CA; Opgenorth TJ J Med Chem; 1993 Feb; 36(4):468-78. PubMed ID: 8474103 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and structure-activity relationship studies of 1,3-disubstituted 2-propanols as BACE-1 inhibitors. Kumar AB; Anderson JM; Melendez AL; Manetsch R Bioorg Med Chem Lett; 2012 Jul; 22(14):4740-4. PubMed ID: 22727644 [TBL] [Abstract][Full Text] [Related]
40. Redesign of the substrate specificity of human cathepsin D: the dominant role of position 287 in the S2 subsite. Scarborough PE; Dunn BM Protein Eng; 1994 Apr; 7(4):495-502. PubMed ID: 7913221 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]